Zoledronic acid for treatment of osteopenia and osteoporosis in women with primary breast cancer undergoing adjuvant aromatase inhibitor therapy: a 5-year follow-up
Title:
Zoledronic acid for treatment of osteopenia and osteoporosis in women with primary breast cancer undergoing adjuvant aromatase inhibitor therapy: a 5-year follow-up
Author:
Majithia, Neil Atherton, Pamela J. Lafky, Jacqueline M. Wagner-Johnston, Nina Olson, Janet Dakhil, Shaker R. Perez, Edith A. Loprinzi, Charles L. Hines, Stephanie L.